Antimicrobial resistance has been seriously threatening human health, and discovering new antimicrobial agents from the natural resource is still an important pathway among various strategies to prevent resistance. Guanidine-containing polyhydroxyl macrolides, containing a polyhydroxyl lactone ring and a guanidyl side chain, can be produced by many actinomycetes and have been proved to possess many bioactivities, especially broad-spectrum antibacterial and antifungal activities. To explore the potential of these compounds to be developed into new antimicrobial agents, a review on their structural diversities, spectroscopic characterizations, bioactivities, acute toxicities, antimicrobial mechanisms, and the structure-activity relationship was first performed based on the summaries and analyses of related publications from 1959 to 2019. A total of 63 guanidine-containing polyhydroxyl macrolides were reported, including 46 prototype compounds isolated from 33 marine and terrestrial actinomycetes and 17 structural derivatives. Combining with their antimicrobial mechanisms, structure-activity relationship analyses indicated that the terminal guanidine group and lactone ring of these compounds are vital for their antibacterial and antifungal activities. Further, based on their bioactivities and toxicity analyses, the discovery of guanidyl side-chain targeting to lipoteichoic acid of Staphylococcus aureus indicated that these compounds have a great potency to be developed into antimicrobial and anti-inflammatory drugs.
Introduction
Antimicrobial resistance has become a serious threat to human health and economic development [1] . Many strategies involving the development of new antimicrobial agents [2] , the revival of old antibiotics [3, 4] , and combination therapy had been putting forward to fight or delay resistance [5] . On the one hand, our group has been researching the practice and law of drug combinations to prevent antimicrobial resistance [5] [6] [7] ; on the other, we have been trying our best to discover new antimicrobial agents. Guanidine-containing polyhydroxyl macrolides can be generally biosynthesized by many actinomycetes [8] [9] [10] , and all these compounds contain a lactone ring and a guanidyl side chain. Azalomycin F, a complex including three main compounds, F 3a , F 4a , and F 5a , isolated from the broth of Streptomyces hygroscopicus var. azalomyceticus [11] [12] [13] [14] , was the first one reported. The planar structures of these three compounds were established by Namikoshi, Iwasaki, and Chandra et al. from 1982 to 1995 [13] [14] [15] [16] [17] , and revised by Yuan et al. in 2011 [18] . Contemporaneously, many other
Structural Diversity
Guanidine-containing polyhydroxyl macrolides are widely produced by actinomycetes, especially streptomycetes. Depending on the atom number composed of the lactone ring, they can be classified into three types: 32-, 36-and 40-membered polyhydroxyl macrolides. Until 2019, 48 guanidine-containing polyhydroxyl macrolides have been isolated and identified, which include seven 32-membered (1-7, Figure 1 ), thirty-six 36-membered (8-43, Figure 2 ), and five 40-membered (44-48) macrolides ( Figure 3 ). All these compounds have a guanidyl side chain and a lactone ring, which includes a six-membered hemiketal ring, while there are differences at (1) the chain length (nine or eleven carbons), methyl number (one or two), and double bond position of guanidyl side chains [35] ; (2) the atom number composed of the lactone ring (32, 36, or 40) ; (3) the number of malonyl monoesters (1 or 2), and their sites (C-19, C-23, or C-25) linking at the lactone ring; (4) the hydroxyl, methyl, and double bond numbers of the lactone ring. Simultaneously, all hydroxyl and methyl groups, except for those on six-membered hemiketal ring, present 1,3-, 1,5-, 1,7-, or 1,9-substitution characteristics, which include 1,3,5-, 1,5,7-, 1,3,5,7-, and 1,3,5,7,9-substitutions, and so on, and double bonds or carbonyl groups can be considered as a potential hydroxyl group as they can be, respectively, formed by the dehydration or oxidation of hydroxyl groups. These structural characterizations can be interpreted by the biosynthesis of guanidine-containing macrocyclic polyketides [8] [9] [10] and are very helpful for the structural elucidation of these compounds. However, the natural existence of compounds 37 and 39 cannot be explained as they share the same origin for guanidinobutanoate starter units in their biosynthesis pathways [9] .
Moreover, compound RP 63834 (48, Figure 3 ) has a 41-membered lactone ring and a guanidyl side-chain containing eight carbons [36] , which is different from the general character (a 32-, 36-, or 40-membered ring and a 9-or 11-carbon guanidyl side-chain) of other polyhydroxyl macrolides and is not in accordance with the rule that the positions of the ketone group are (n−2)/2 position in n-membered macrocyclic lactones [35] . Maybe, one of three methylene at C 46 , C 48 , and C 49 position [36] should be assigned to its guanidyl side-chain, and compound RP 63834 is a 40-membered polyhydroxyl macrolide. Thereby, we deduced that compound RP 63834 was likely a compound 44. The numbers, names, and corresponding sources and references of all these compounds are shown in Table 1 .
ical structures of 32-membered guanidine-containing polyhydroxy 7). Among 33 guanidine-containing polyhydroxyl macrolide-producing strains (Table 1) , sixteen belong to Streptomyces hygroscopicus, ten are unidentified species of streptomycete genus, and other strains are Streptomyces lasiicapitis 3H-HV17(2)T [37] , Streptomyces malaysiensis MJM1968 [27] , Streptomyces olivaceus Tü 4018 [38] , Streptomyces violaceoniger TÜ 905 [39] , Streptomyces violaceusniger RS-22 [40] , and two actinomycete strains HIL Y-9120362 and MT2617-2 [41, 42] . To understand the affinity of these strains, the phylogenetic tree ( Figure 4 ) was constructed using the neighbor-joining algorithms (some similar strains belonging to the same species of these strains, which have no 16S rRNA gene sequences, were used) [43] . Briefly, their 16S rRNA gene sequences were aligned against sequences of reference strains using the BLAST program (http://www.ncbi.nlm.nih.gov/). All the selected DNA multiple sequences were matched by means of software package Clustal_X 1.83 [44] , and evolution distances were calculated using the Kimura2-Parameter model of MEGA version 6.0 [45] . Based on 1000 replicates, the confidence coefficient of the phylogenetic tree was evaluated using bootstrap analysis [46] . From Figure 4 , there are no obvious distribution rules of species and genera between these guanidine-containing polyhydroxyl macrolides and their producing strains. Namely, the same macrolide can be produced by several species and genera with different genetic distances. Moreover, compound RP 63834 (48, Figure 3 ) has a 41-membered lactone ring and a guanidyl side-chain containing eight carbons [36] , which is different from the general character (a 32-, 36-, or 40-membered ring and a 9-or 11-carbon guanidyl side-chain) of other polyhydroxyl macrolides and is not in accordance with the rule that the positions of the ketone group are (n-2)/2 position in nmembered macrocyclic lactones [35] . Maybe, one of three methylene at C46, C48, and C49 position [36] should be assigned to its guanidyl side-chain, and compound RP 63834 is a 40-membered polyhydroxyl macrolide. Thereby, we deduced that compound RP 63834 was likely a compound 44. The numbers, names, and corresponding sources and references of all these compounds are shown in Table 1 . Among 33 guanidine-containing polyhydroxyl macrolide-producing strains (Table 1) , sixteen belong to Streptomyces hygroscopicus, ten are unidentified species of streptomycete genus, and other strains are Streptomyces lasiicapitis 3H-HV17(2)T [37] , Streptomyces malaysiensis MJM1968 [27] , selected DNA multiple sequences were matched by means of software package Clustal_X 1.83 [44] , and evolution distances were calculated using the Kimura2-Parameter model of MEGA version 6.0 [45] . Based on 1000 replicates, the confidence coefficient of the phylogenetic tree was evaluated using bootstrap analysis [46] . From Figure 4 , there are no obvious distribution rules of species and genera between these guanidine-containing polyhydroxyl macrolides and their producing strains. Namely, the same macrolide can be produced by several species and genera with different genetic distances.
Figure 4.
Neighbor-joining tree based on the 16S rRNA gene sequences of some strains producing guanidine-containing polyhydroxyl macrolide. Some similar strains belonging to the same species of these strains, which have no 16S rRNA gene sequences, were used. Neighbor-joining tree based on the 16S rRNA gene sequences of some strains producing guanidine-containing polyhydroxyl macrolide. Some similar strains belonging to the same species of these strains, which have no 16S rRNA gene sequences, were used.
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These molecules contain many chair centers (more than eighteen). As they have lager flexibility attributed to the larger ring and the longer side-chain, their single crystals were hardly obtained for determining the stereochemistry using an x-ray single diffraction method [15] . Simultaneously, other methods [68] , such as optical rotatory dispersion (ORD), vibrational circular dichroism (VCD), and electrostatic circular dichroism (ECD), were also difficult to have assigned their absolute configurations because of the complexity and flexibility of these compounds. Thereby, most compounds only presented their planar structures except for the relative configurations of azalomycin F analogs and derivatives (8) (9) (10) (13) (14) (15) (16) (17) (18) (19) [24, 25] and the proposed absolute configurations of niphimycin analogs (27) (28) (29) (30) (31) (32) (33) [53] .
Moreover, 15 derivatives (49-63, Figure 5 ) were synthesized from copiamycin, azalomycin F, guanidylfungin A, and niphimycin, which mainly involved the etherification of hemiketal hydroxyl and/or the hydrolysis of malonyl moiety. Their numbers, names, and corresponding raw materials and references are listed in Table 2 . 
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Streptomyces violaceusniger RS-22 [22, 38] (1995) These molecules contain many chair centers (more than eighteen). As they have lager flexibility attributed to the larger ring and the longer side-chain, their single crystals were hardly obtained for determining the stereochemistry using an x-ray single diffraction method [15] . Simultaneously, other methods [68] , such as optical rotatory dispersion (ORD), vibrational circular dichroism (VCD), and electrostatic circular dichroism (ECD), were also difficult to have assigned their absolute configurations because of the complexity and flexibility of these compounds. Thereby, most compounds only presented their planar structures except for the relative configurations of azalomycin F analogs and derivatives (8-10, 13-19) [24, 25] and the proposed absolute configurations of niphimycin analogs (27) (28) (29) (30) (31) (32) (33) [53] .
Moreover, 15 derivatives (49-63, Figure 5 ) were synthesized from copiamycin, azalomycin F, guanidylfungin A, and niphimycin, which mainly involved the etherification of hemiketal hydroxyl and/or the hydrolysis of malonyl moiety. Their numbers, names, and corresponding raw materials and references are listed in Table 2 . Table 2 . Structural derivatives (49-63) of some guanidine-containing polyhydroxyl macrolides.
Compounds
Derivatives Name Raw Materials References (Publication Time) 49 17 
Spectroscopic Characterization
As the chemical structures of these compounds have many similar fragments and groups, many NMR signals are close to each other, and some even overlap. These will increase the difficulties of their structural elucidations, while some regularity spectroscopic characterizations could be summarized, which would be very conducive to the structural elucidations of these compounds.
For the guanidyl side-chain, their guanidyl carbon signals at 157.3 to 158.3 ppm are easily observed from their 13 C NMR spectra, and their chemical shifts decrease from approximately 158.7, 158.3 to 157.3 when the methyl number linking with guanidino nitrogen increases from 0, 1 to 2 [18, 22, 25, 53] . These are also confirmed by the proton signals of N-methyl at 2.8 to 2.9 ppm on the 1 H NMR spectra. Moreover, the stereochemistry of chain double bond is generally oriented in E-configuration. This is hardly established from the NMR spectrometric data due to overlapping signals; however, it can be confirmed by comparing the band at 969 cm −1 in the IR spectrum with the spectral data in the book [18, 72] .
For the lactone ring, many methyl and oxygenated methine signals can be observed from their 13 C NMR spectra. As all these compounds share polyketide biosynthesis pathway [8] [9] [10] 53] , some general substitution characteristics of the hydroxyls and methyl groups linking on the lactone ring and guanidyl side-chain, such as 1,3-, 1,5-, 1,7-, 1,9-, 1,3,5-, 1,3,5,7-, 1,5,7-, and 1,3,5,7,9-substitutions, are very useful for their structural elucidations and NMR signal assignments. Some NMR data, including a quaternary hemiketal carbon at 99 to 100 ppm, the carbon at about 80 ppm and proton at 4.81 ppm of oxygenated methine forming lactone, and the proton at 5.23 ppm of oxygenated methine linking malonyl moiety will be also helpful for their structural elucidations. Furthermore, the presence or not of a conjugated diene and/or an α, β, γ, and δ-unsaturated acid (or ester) group can be easily deduced from whether there are UV absorption maxima at 240 nm (lgε more than 4) and/or 269 nm (lgε more than 4) [13, 18] . For the malonyl moiety, the carbon signal of methylene is hardly observed (sometimes a little) in a protic solvent, such as methanol-d 4 , as the keto-enol tautomerization rapidly occurs [18, 53] , while it is easily detected in an aprotic solvent, such as DMSO-d 6 . Simultaneously, the two protons present multiple peaks in the 1 H NMR spectrum as they quickly exchange with deuterium at the measurement conditions, especially at higher temperatures [18] .
Bioactivity
Guanidine-containing polyhydroxyl macrolides have been experimentally documented to possess broad-spectrum antibacterial and antifungal activities, and they can remarkably inhibit the growth of Gram-positive bacteria, yeast, and fungi (Table 3) [25, 28, 34, 38, 51, 53, 58, 64] . Moreover, they also show antitrichomonal and antitumor activities [25, 73, 74] .
Azalomycin F has remarkable bioactivities against Gram-positive bacteria, yeast, fungi, and protozoa [17, 34, 73, 75] , and some clinical studies on its anti-trichomoniasis and anti-candida infectious effects were performed [34] , while no corresponding drug was approved in the clinic. Stefanelli et al. discovered that niphimycin (28) and azalomycin F (8-10) could inhibit the type-I interleukin-1 receptor [55] . Moreover, they had remarkable activities against phytopathogenic fungi, such as Fusarium oxysporum, Fusarium moliniforme, Asparagus officinalis, Rhizoctonia solani, Colletotrichum gloeosporioides, and Alternaria mali [17, 36] .
Hamagishi et al. [48] discovered that copiamycin A (1), azalomycin F (8-10), and scopafungin (niphimycin, 28) could inhibit the secretion of gastric acid in the gastric parietal cells of rats by inhibiting H + /K + -ATPase with the IC 50 s of 15.7, 16.4, and 35.9 µg/mL, respectively. The inhibitory potency of copiamycin was found to be comparable to that of omeprazole and SCH-28080, both specific inhibitors of the gastric H + /K + -ATPase in vitro and in vivo [48] . 
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Ten isolates of S. aureus ATCC 33592 (4~8) [78] 11
The diameter of the zone of inhibition (mm): C. albicans (11) , Penicillium digitatum (15), Fusarium culmorum 100 (17) [21, 53, 58, 60] In addition, Reusser [56] proposed that niphimycin (scopafungin, 28) was an inhibitor of mitochondrial oxidative phosphorylation and respiration, and mainly a decoupling agent for oxidative phosphorylation. Furthermore, Mogi et al. [81] discovered that niphimycin had inhibitory activity against NADH dehydrogenase (NDH-II), and deduced that niphimycin had a great potential to become an antibacterial drug as it showed no severe effect on mammalian respiratory enzymes.
Using an NIH3T3 cell line, a screening system for Ras signal inhibitors was developed to search for anti-cancer agents by Futamura et al. [74] . Malolactomycin D (47) was identified as a selective inhibitor of Ras-responsive transcription. The expression of matrix metalloproteinases MMP-1 and MMP-9 in NIH3T3 cells line could be reduced by treatment with malolactomycin D at the translational and transcriptional levels, and this was achieved likely by inhibiting the activation of p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) [82, 83] . As MMPs contribute to tumor growth, invasion, and metastasis by promoting the degradation of extracellular matrix and maintaining the tumor microenvironment [84, 85] , malolactomycin D suppressing the transformation activity of Ras-transformed cells by inhibiting the expression of Ras-inducible genes, such as MMP-1 and MMP-9, indicated that it was expected to be a new anticancer agent with high efficiency and low toxicity.
Ko et al. [40] isolated a phospholipase C inhibitor (PLC) from the culture medium of actinomycete MT2617-2 and named it as MT2617-2B, which produced its two isomers having the same molecular weight by standing in methanol solution at room temperature, copiamycin and niphithricin A. Besides antimicrobial activities against S. aureus and C. albicans, MT2617-2B had a remarkable inhibitory activity against phospholipase C with the IC 50 values against PLC-γ1 and PLC-β1 of 25 and 50 µg/mL, respectively.
Acute Toxicity
To understand the safety of these compounds, the median lethal dose (LD 50 ) and maximal tolerable dose (MTD or LD 0 ) of some guanidine-containing polyhydroxyl macrolides were determined. As shown in Table 4 , the LD 50 or LD 0 doses of each compound successively decreased from oral, subcutaneous, intraperitoneal to intravenous administrations. Moreover, Benziger and Edelson reported that azalomycin F administered intravaginally presented limited absorption [86] . Thereby, we deduced that azalomycin F administered orally was likely difficult to be absorbed, and this might be in accordance with the experimental results of its acute toxicities in different administrations. It was inexplicable that the LD 50 or LD 0 of neocopiamycins A and B administered intraperitoneally were more than 1000 mg/kg, which indicated that they had low toxicity, while the LD 50 or LD 0 of neocopiamycins A and B administered intravenously were only more than 30 or 25 mg/kg. Moreover, these compounds, except for neocopiamycins A and B in Table 4 , had similar acute toxicities when they were administrated intraperitoneally. This indicated that their toxicities might be attributed to the lactone ring and guanidyl side-chain, which were also mainly responsible for their antimicrobial activities, and likely had nothing to do with the size of lactone ring and the numbers of hydroxyl and methyl groups. It was worth noting that the purities of compounds or mixtures used for the acute toxicity test would fluctuate the experimental results; however, very few publications have provided this information. [38] a : a mixture of twelve azalomycin F analogs was used in the determination of LD 50 . b : a mixture of RS-22 A, B, and C was used in the determination of LD 50 .
Antimicrobial Mechanisms
As these compounds had remarkable inhibitory activities against Gram-positive bacteria and fungi, related researches mainly focused on antibacterial and antifungal mechanisms. Previous works indicated that cell membrane was the main action site of them against bacteria and fungi, and these compounds could change the plasma membrane permeability and lead to the leakage of cellular substances [26] [27] [28] 30 ].
Antibacterial Mechanisms
As Sugawara reported [75] , azalomycin F could lead to the leakage of cellular substances to kill Bacillus subtilis, while detailed mechanisms had not been further reported because their chemical structures were not clear at that time. Inspired by the fact that the antimicrobial activities of azalomycin F and copiamycin could be reversed in the same manner by the phospholipid fraction of the bacteria, and various phospholipids, such as phosphatidylglycerol (PG) and phosphatidylcholine [89] , Yuan et al. [26] discovered that azalomycin F 5a , the main component of azalomycin F, could lead to the leakage of cellular substances possibly by increasing permeability to kill S. aureus and confirmed that cell-membrane lipids, especially 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1 -rac-glycerol) (DPPG), might be important targets of azalomycin F 5a against S. aureus after its relative configurations were assigned [24, 26] . Further researches indicated that azalomycin F 5a , increasing the cell membrane permeability of S. aureus, was likely achieved by the synergy of its lactone ring binding to the polar head of phospholipid and its guanidyl side-chain targeting to lipoteichoic acid (LTA), and which had eventually led to the autolysis of S. aureus cells [30] . The compositional analysis indicated that PG, lysyl-phosphatidylglycerol (LPG), and cardiolipin (CL) were three major components of S. aureus cell-membrane phospholipid, and PG was the largest one [90, 91] . Simultaneously, the content of lysyl-DPPG in the cell-membrane lipids would increase when S. aureus was resistant to daptomycin [90] . Thereby, molecular dynamics simulation, showing that azalomycin F 5a had greater adhesive force to plasma membrane assembled by DPPG plus lysyl-DPPG than by DPPG, indicated that azalomycin F 5a likely had greatly antagonistic activity to daptomycin-resistant S. aureus strains, and then proposed that these compounds had a great potency to be developed into new antimicrobial agents as LTA is also an important target for new antibiotics [92, 93] .
Antifungal Mechanism
Although these compounds can change the cell membrane permeability of microbe and lead to the leakage of cellular substances, there are different mechanisms of them against bacteria and fungi as the components of their cell envelopes are different.
Sugawara [94] discovered that azalomycin F could cause the leakage of cellular substance from the cells of C. albicans and the lysis of rabbit erythrocytes, and strongly inhibit amino acid incorporation into cellular protein and oxidative deamination of amino acid metabolism, but not decarboxylation and transamination. Simultaneously, it insignificantly inhibited the incorporation of phosphate into nucleic acids and the glycolytic pathway and did not exert any noticeable inhibition in cell-free protein-synthesizing systems of E. coli, rat liver, and C. albicans, and mitochondrial enzyme systems. Thereby, the cell surface was proposed as the primary site of azalomycin F acting on C. albicans [94] . Moreover, antifungal mechanisms of other guanidine-containing polyhydroxyl macrolides also confirmed that these compounds, such as niphimycins and copiamycins, could act on the cell membrane of fungi and alter their membrane permeability to cause the leakage of cellular components [27, 28, 89] . Further researches proposed that copiamycin and zalomyci F disrupted the cell membrane of fungi by binding to the cell-membrane phospholipids [89] . Thorough antifungal mechanism indicated that a synergistic combination of direct plasma membrane damage and oxidative stress was a cause of antifungal activity of niphimycin against Saccharomyces cerevisiae [29] , and proposed that niphimycin disrupted the plasma membrane by directly interacting with phospholipids, such as phosphatidylcholine, but did not interact with ergosterol, a molecular target of amphotericin B. At the same time, Nakayama et al. [29] , depending on the differences in the structures of niphimycin and amphotericin, suggested that the ability of niphimycin damaging the plasma membrane and/or generating ROS residues was primarily attributed to the alkyl side chain and terminal guanidine. In addition, Uno et al. [77] inferred that copiamycin, a 32-membered guanidyl polyol macrolide, had ionophoretic activity and could form a conformation with a ring or cavity that focuses the oxygens in lactone ring with various cations into a complex.
Antimicrobial Structure-Activity Relationship
As antimicrobial activity is one of the most important bioactivities of these compounds, most of them presented their minimum inhibitory concentration (MIC) against bacteria and fungi (Table 3) when they were discovered. Thereby, the structure-activity relationships of these compounds against bacteria and fungi can be summarized as follows:
(1) The atom number composed of the lactone ring is less important for their antimicrobial activities [50, 66, 86] and acute toxicity ( Table 4) .
It is worth noting that 32-membered guanidine-containing polyhydroxyl macrolide TCM-34 shows remarkable antifungal activity (MIC, 1.6 to 3.1 µg/mL), while presents very weak antibacterial activity (MIC, more than 100 µg/mL) [52] .
(2) Antimicrobial activity is significantly affected by the guanidyl side-chain, especially by the terminal guanidine group, which is a key for their antibacterial and antifungal activities. The substitution of guanidino residue to urea will lead to the loss of antibacterial activity and significantly narrow the antifungal spectrum [29, 38, 95] , while the number of methyl groups linking on guanidine has a little or no effect on the antimicrobial activity [12, 18, 20] . Moreover, enough length (9 or 11 carbons) of the side chain is necessary for the antimicrobial bioactivity [96] .
(3) The hydrolysis of the lactone ring will lead to the loss of antimicrobial activity [95] . The six-membered hemiketal ring plays an essential role in the antimicrobial activity, and the opening of a six-membered hemiacetal ring will remarkably decrease the antimicrobial activity [50] . Simultaneously, the etherification of C 17 hydroxyl will slightly reduce the antimicrobial activity, and·sometimes this decrease can be counteracted by the increase of antimicrobial activity due to the removal of the malonyl group [21, 50, 58, 70, 71] .
(4) There is no significant influence on the antimicrobial activity when hydrogenation, methyl'removal, or/and methyl substitution occur to the double bond of the lactone ring. Similarly, methyl substitution of the double bond on the guanidyl side-chain is less important for the antimicrobial activity [20, 23, 38, 63] .
(5) The introduction of malonyl moiety will reduce the antimicrobial activity [21, 50, 53, 70, 71, 97] . The more the number of malonyl substitution, the weaker the antibacterial activity of these compounds. However, the position of malonyl substitution shows no influence on their antibacterial activities [53] .
As we reported [30] , azalomycin F 5a could increase the cell membrane permeability of S. aureus and eventually lead to the autolysis of S. aureus cells, by the synergy of its lactone ring binding to the polar head of phospholipid and its guanidyl side-chain targeting to LTA, which is a vital anion component anchoring on the phospholipid bilayer of Gram-positive bacteria. This was in accordance with the above structure-activity relationship that the lactone ring and the terminal guanidyl side-chain were vital for the antimicrobial activity. As the carboxyl group of malonyl monoester can theoretically form an intramolecular hydrogen bond or ionic bond with the guanidyl of side-chain, the existence of malonyl will likely block the interaction between the guanidyl of side-chain and LTA. This was confirmed by their 3D molecular structures obtained by ChemBio3D Ultra 12.0 run with MM2 calculation ( Figure 6 ) and by pharmacophore model of 36-membered guanidine-containing polyhydroxyl macrolides using Discovery Studio 3.5 (Figure 7) , and could explain why the antimicrobial activity of azalomycin F was greatly reduced by phospholipids containing an acidic phosphoryl group [98] . Further, this can also explain why the introduction of malonyl will greatly reduce the antimicrobial activity and coincides with the above structure-activity relationship (5) . From Figure 5 , we can deduce that the substituted position (C-19, C-23, or C-25) of malonyl coincides with the spatial distance of the intramolecular salt or hydrogen bond formation between the terminal guanidine and the carboxyl group of malonyl monoester. This will likely reduce the interaction between the guanidyl of side-chain and LTA, and then reduce the antimicrobial activity of these compounds. Inspired by a previous publication [99] , all these above indicate that the introduction of malonyl may be self-protection of actinomycetes producing guanidine-containing polyhydroxyl macrolide, through which they can be free from the poison and injury of secondary metabolites produced by themselves. Moreover, the demalonylation of these compounds not only increases the antimicrobial activity but also yields a basic compound, which has a better water solubility, especially for its hydrochloride [50, 71] . les 2019, 24, x 16 ydroxyl macrolides using Discovery Studio 3.5 (Figure 7) , and could explain why icrobial activity of azalomycin F was greatly reduced by phospholipids containing an a horyl group [98] . Further, this can also explain why the introduction of malonyl will gr e the antimicrobial activity and coincides with the above structure-activity relationship Figure 5 , we can deduce that the substituted position (C-19, C-23, or C-25) of malonyl coin the spatial distance of the intramolecular salt or hydrogen bond formation between the term idine and the carboxyl group of malonyl monoester. This will likely reduce the intera en the guanidyl of side-chain and LTA, and then reduce the antimicrobial activity of t ounds. Inspired by a previous publication [99], all these above indicate that the introducti yl may be self-protection of actinomycetes producing guanidine-containing polyhydr lide, through which they can be free from the poison and injury of secondary metabo ced by themselves. Moreover, the demalonylation of these compounds not only increase icrobial activity but also yields a basic compound, which has a better water solubility, espec hydrochloride [50, 71] . Figure 6 . The 3D molecular structures of azalomycin F5a (a) and 23-demalonyl azalomycin F5a (b) obtained by ChemBio3D Ultra 12.0. (a) An intramolecular hydrogen bond or ionic bond (dotted line) is formed between the guanidyl (nitrogen atoms colored blue) of sidechain and the carboxyl group (oxygen atoms colored red) of malonyl monoester, but there is no bond formation in case of (b).
Figure 7.
Pharmacophore model of 36-membered guanidine-containing polyhydroxyl macrolides obtained by Discovery Studio 3.5. Ten pharmacophore features were constructed, and was successively F1:Acc|Don (Hydrogen bond acceptor or donor); F2:Acc (Hydrogen bond acceptor); F3, F4, F6, and F7:Hyd (Hydrophobic region); F5:Don&Acc (Hydrogen bond donor and acceptor); F8 Acc2|Don2 (Hydrogen bond acceptor or donor projected); and F9 and F10:Don2&Acc2 (Hydrogen bond donor and acceptor projected). 
Conclusions
To date, a total of 63 guanidine-containing polyhydroxyl macrolides were reported, including 48 prototype compounds isolated from 33 actinomycete strains and 15 structural derivatives. These compounds have various bioactivities, such as broad-spectrum antimicrobial activity, anti-trichomonas, anti-tumor, and inhibitory activities against H + /K + -ATPase, mitochondrial oxidative phosphorylation, NADH dehydrogenase, and phospholipase C, while they also have a little toxicity. Structure-activity relationships indicate that both the terminal guanidine group and the lactone ring are the key for their antimicrobial activities. As LTA anchoring to the cell membrane is an important polymer for the resistance to cationic antibiotics, the autolysin regulation, and the cell division of Gram-positive bacteria, LTA synthase gradually becomes a proposed drug target for the development of antibiotics against drug-resistant Gram-positive bacteria [92, 93, 100, 101] . Thereby, the discovery of guanidyl side-chain targeting to lipoteichoic acid indicates these compounds have a great potency to be developed into antimicrobial and anti-inflammatory drugs.
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